ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+16.53%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
(+11%)
Cap. Flow
+$2.77M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
67.79%
Holding
35
New
8
Increased
9
Reduced
5
Closed
11
Top Buys
| 1 |
LENZ
LENZ Therapeutics
LENZ
|
$10.1M |
| 2 |
Oric Pharmaceuticals
ORIC
|
$4.93M |
| 3 |
Replimune Group
REPL
|
$4.91M |
| 4 |
Soleno Therapeutics
SLNO
|
$4.89M |
| 5 |
CMPS
Compass Pathways
CMPS
|
$4.16M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$12.4M |
| 2 |
Axsome Therapeutics
AXSM
|
$8.41M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$6.57M |
| 4 |
Trevi Therapeutics
TRVI
|
$4.32M |
| 5 |
Insmed
INSM
|
$3.76M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CG Oncology
CGON
$2.04B
| – | – |
-132,298
| Closed | -$3.24M |
|
27
Context Therapeutics
CNTX
$75.4M
| – | – |
-1,157,448
| Closed | -$708K |
|
28
Dianthus Therapeutics
DNTH
$759M
| – | – |
-80,584
| Closed | -$1.46M |
|
29
Edgewise Therapeutics
EWTX
$1.51B
| – | – |
-102,650
| Closed | -$2.26M |
|
30
Janux Therapeutics
JANX
$1.37B
| – | – |
-81,292
| Closed | -$2.19M |
|
31
Ultragenyx Pharmaceutical
RARE
$2.89B
| – | – |
0
| – | – |
|
|
SWTX
32
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-281,139
| Closed | -$12.4M |
|
|
33
Trevi Therapeutics
TRVI
$883M
| – | – |
-686,219
| Closed | -$4.32M |
|
34
Tyra Biosciences
TYRA
$675M
| – | – |
-107,244
| Closed | -$997K |
|
35
Xenon Pharmaceuticals
XENE
$2.98B
| – | – |
-69,603
| Closed | -$2.34M |
|